FHLC vs. XAR
FHLC (Fidelity MSCI Health Care Index ETF) and XAR (SPDR S&P Aerospace & Defense ETF) are both exchange-traded funds - FHLC is a Health & Biotech Equities fund tracking the MSCI USA IMI Health Care Index, while XAR is a Aerospace & Defense fund tracking the S&P Aerospace & Defense Select Industry Index. Both are passively managed. Over the past 10 years, FHLC returned 9.56%/yr vs 17.82%/yr for XAR. A 0.52 correlation means they provide meaningful diversification when combined. FHLC charges 0.08%/yr vs 0.35%/yr for XAR.
Performance
FHLC vs. XAR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FHLC achieves a -1.04% return, which is significantly lower than XAR's 12.43% return. Over the past 10 years, FHLC has underperformed XAR with an annualized return of 9.56%, while XAR has yielded a comparatively higher 17.82% annualized return.
FHLC
- 1D
- -0.23%
- 1M
- 5.45%
- YTD
- -1.04%
- 6M
- 0.82%
- 1Y
- 16.51%
- 3Y*
- 7.13%
- 5Y*
- 4.80%
- 10Y*
- 9.56%
XAR
- 1D
- -0.54%
- 1M
- 2.15%
- YTD
- 12.43%
- 6M
- 16.39%
- 1Y
- 37.23%
- 3Y*
- 32.47%
- 5Y*
- 15.97%
- 10Y*
- 17.82%
FHLC vs. XAR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | -1.04% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 18.13% | 21.94% | 4.71% | 23.34% |
XAR SPDR S&P Aerospace & Defense ETF | 12.43% | 46.15% | 23.32% | 23.79% | -5.02% | 2.31% | 6.18% | 39.33% | -4.58% | 33.00% |
Correlation
The correlation between FHLC and XAR is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.38 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.46 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2013 | 0.52 |
Over the past year, the correlation between FHLC and XAR has dropped to 0.27 - well below their long-term average of 0.52, suggesting their price drivers have been diverging.
FHLC vs. XAR - Sectors Allocation Comparison
Sectors
FHLC
XAR
Healthcare
-
Financial Services
-
Technology
Industrials
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
FHLC
XAR
-
Financial Services
FHLC
XAR
-
Technology
FHLC
XAR
Industrials
FHLC
XAR
Basic Materials
FHLC
-
XAR
-
Communication Services
FHLC
-
XAR
-
Consumer Cyclical
FHLC
-
XAR
-
Consumer Defensive
FHLC
-
XAR
-
Energy
FHLC
-
XAR
-
Real Estate
FHLC
-
XAR
-
Utilities
FHLC
-
XAR
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FHLC vs. XAR — Risk / Return Rank
FHLC
XAR
FHLC vs. XAR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and SPDR S&P Aerospace & Defense ETF (XAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FHLC | XAR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.25 | ||
| Sortino ratioReturn per unit of downside risk | -0.24 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.23 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.60 | 2.17 | -0.58 |
| Martin ratioReturn relative to average drawdown | 4.00 | 6.13 | -2.13 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FHLC | XAR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 1.39 | -0.25 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.32 | 0.68 | -0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.73 | -0.16 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.62 | 0.84 | -0.22 |
Drawdowns
FHLC vs. XAR - Drawdown Comparison
The maximum FHLC drawdown since its inception was -28.76%, smaller than the maximum XAR drawdown of -46.37%. Use the drawdown chart below to compare losses from any high point for FHLC and XAR.
Loading charts...
Drawdown Indicators
| FHLC | XAR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.76% | -46.37% | +17.61% |
Max Drawdown (1Y)Largest decline over 1 year | -10.38% | -17.22% | +6.84% |
Max Drawdown (3Y)Largest decline over 3 years | -16.87% | -19.73% | +2.86% |
Max Drawdown (5Y)Largest decline over 5 years | -17.73% | -32.40% | +14.67% |
Max Drawdown (10Y)Largest decline over 10 years | -28.76% | -46.37% | +17.61% |
Current DrawdownCurrent decline from peak | -4.18% | -7.35% | +3.17% |
Average DrawdownAverage peak-to-trough decline | -5.19% | -6.78% | +1.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.14% | 6.09% | -1.95% |
Volatility
FHLC vs. XAR - Volatility Comparison
The current volatility for Fidelity MSCI Health Care Index ETF (FHLC) is 4.86%, while SPDR S&P Aerospace & Defense ETF (XAR) has a volatility of 9.09%. This indicates that FHLC experiences smaller price fluctuations and is considered to be less risky than XAR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FHLC | XAR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.86% | 9.09% | -4.23% |
Volatility (6M)Calculated over the trailing 6-month period | 10.49% | 22.58% | -12.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.62% | 27.05% | -12.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.02% | 23.46% | -8.44% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.84% | 24.65% | -7.81% |
FHLC vs. XAR - Expense Ratio Comparison
FHLC has a 0.08% expense ratio, which is lower than XAR's 0.35% expense ratio.
Dividends
FHLC vs. XAR - Dividend Comparison
FHLC's dividend yield for the trailing twelve months is around 1.38%, more than XAR's 0.32% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | 1.38% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
XAR SPDR S&P Aerospace & Defense ETF | 0.32% | 0.40% | 0.66% | 0.54% | 0.50% | 0.83% | 0.63% | 0.75% | 1.19% | 0.76% | 1.09% | 2.31% |
Frequently Asked Questions
FHLC and XAR have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XAR has higher volatility (9.09%) compared to FHLC (4.86%). In terms of maximum drawdown, FHLC dropped -28.76% vs XAR's -46.37%.
On 10-year performance, XAR leads with 17.82% vs 9.56% for FHLC. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.86%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, XAR has performed better with a 17.82% return vs 9.56%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.35% for XAR.
FHLC has the higher dividend yield at 1.38%, compared with 0.32% for XAR.
FHLC is categorized as Health & Biotech Equities, while XAR is Aerospace & Defense. FHLC tracks MSCI USA IMI Health Care Index, while XAR tracks S&P Aerospace & Defense Select Industry Index. They also come from different issuers: Fidelity and State Street. Their fees differ too: 0.08% for FHLC and 0.35% for XAR.
XAR currently has the higher Sharpe Ratio (1.39 vs 1.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FHLC and XAR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer